Here is another article in the NYT series Target Cancer. Target Cancer – A Drug Trial Cycle – Recovery, Relapse, Reinvention – Series – NYTimes.com. One of the many reasons I continue to highlight cancer news here in my blog is that I have found that once your family is in the club, you never…

Target Cancer – After Long Fight, Melanoma Drug Gives Sudden Reprieve A new kind of cancer therapy, it was tailored to a particular genetic mutation that was driving the disease, and after six years of disappointments his faith in the promise of such a “targeted” approach finally seemed borne out. The trial of PLX4032 offers…

Dozens of such “targeted” drugs are emerging from the laboratory, rooted in decades of research and backed by unprecedented investment by pharmaceutical companies, which stand to profit from drugs that prolong life even by weeks. But putting them to their truest test falls to a small band of doctors committed to running experimental drug trials…